BioPharma Dive August 20, 2024
J&J has agreed to pay $600 million upfront for the private company as it works to expand its portfolio of cardiovascular devices.
Dive Brief:
- Johnson & Johnson has agreed to acquire V-Wave, the maker of an implantable device to treat heart failure, in a deal worth up to $1.7 billion.
- J&J will pay $600 million upfront, plus potential additional payments up to about $1.1 billion if regulatory and commercial milestones are met, the company said Tuesday. J&J expects the acquisition to close before the end of the year.
- V-Wave’s device, known as the Ventura Interatrial Shunt, is designed to reduce elevated left atrial pressure in people with congestive heart failure by creating a shunt between the left and right...
Today's Sponsors
Today's Sponsor